Upper Gastrointestinal Tract Hemorrhage, Warfarin, and Urinary Tract Antibiotics

Home>
Specialties>
Infectious Diseases>
Summary and Comment

Upper Gastrointestinal Tract Hemorrhage, Warfarin, and Urinary Tract Antibiotics

Findings from a population-based investigation indicate that cotrimoxazole increased hemorrhage risk among patients on long-term warfarin therapy.

Hemorrhage is a well-known side effect of long-term warfarin use in older patients. Interactions between warfarin and certain other drugs can increase the risk for this complication. In a recent nested case-control study conducted using healthcare databases from Ontario, Canada, researchers examined the risk for upper gastrointestinal (GI) tract hemorrhage among patients receiving both warfarin and antibiotics commonly used to treat urinary tract infections.

The cohort consisted of 134,637 patients aged $≥$ 66 who had been continuously treated with warfarin for $≥$ 180 days. Of these patients, 45,972 had received a concomitant prescription for an antibiotic of interest. The 2151 patients (1.6%) who were hospitalized for upper GI tract hemorrhage during the study period were considered cases; up to 10 age- and sex-matched controls were selected for each case.

Cases were nearly four times as likely as controls to have received cotrimoxazole (adjusted odds ratio, 3.84; 95% confidence interval, 2.33–6.33). Ciprofloxacin use was also associated with increased bleeding risk (AOR, 1.94; 95% CI, 1.28–2.95). No significant association was seen between hemorrhage and use of amoxicillin, ampicillin, nitrofurantoin, or norfloxacin.

Comment: Although increasing drug resistance among aerobic gram-negative bacilli has limited the use of cotrimoxazole, this agent is still prescribed for urinary tract infections caused by susceptible pathogens. In addition, it has seen growing use for treating infections with Stenotrophomonas maltophilia, skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus, and (as long-term suppressive therapy) certain medical device–related infections.

Among older patients taking warfarin, an antibiotic other than cotrimoxazole or ciprofloxacin should be prescribed. If an alternative is not feasible, both prothrombin time and the international normalized ratio should be monitored closely during and after antibiotic therapy.

— Larry M. Baddour, MD

Published in Journal Watch Infectious Diseases April 28, 2010

Citation(s):

Fischer HD et al. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: A population-based study. Arch Intern Med 2010 Apr 12; 170:617.

Medline abstract (Free)

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Professional specialty:*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests (for example, financial stakes or professional relationships):

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.